2025-07-28 - Analysis Report
Okay, here's an analysis of Transmedics Group Inc (TMDX) based on the provided data, formatted as requested:

## TMDX (Transmedics Group Inc) Analysis

Transmedics Group Inc. is a medical technology company focused on developing and delivering innovative organ preservation systems for transplant therapy.

### 1. Performance vs. S&P 500 (VOO)

*   **TMDX Cumulative Return:** 226.59%
*   **VOO Cumulative Return:** 71.23%
*   **Absolute Divergence:** 155.1
*   **Relative Divergence:** 60.8

**Analysis:** TMDX has significantly outperformed the S&P 500. The absolute divergence of 155.1 indicates a substantial difference in returns. A relative divergence of 60.8 suggests TMDX's performance is in the upper-middle range of its historical outperformance relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2019-2021  | -4.0%  | 63.4% | -52.0% | 0.0  | 0.7    |
| 2020-2022  | 140.0% | 68.3% | 138.0% | 0.1  | 2.1    |
| 2021-2023  | 95.0%  | 69.4% | 77.0%  | 0.2  | 2.7    |
| 2022-2024  | 147.0% | 82.8% | 121.0% | 0.2  | 2.1    |
| 2023-2025  | 108.0% | 82.8% | 56.0%  | 0.5  | 3.7    |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows high growth rates in recent periods (2020-2025).
*   **MDD:** The Maximum Drawdown is high, indicating significant volatility and risk.
*   **Alpha:** Alpha is consistently positive, indicating TMDX is outperforming its benchmark on a risk-adjusted basis.  The negative Alpha for 2019-2021 suggests underperformance during that period.
*   **Beta:** Beta values are low but increasing over time, suggesting TMDX's price movement is becoming slightly more correlated with the market but still relatively independent.

### 2. Recent Price Action

*   **Current Price:** 108.12
*   **Last Market Data:** {'price': 108.12, 'previousClose': 106.79, 'change': 1.25}
*   **5-day Moving Average:** 106.818
*   **20-day Moving Average:** 118.3463
*   **60-day Moving Average:** 121.1742

**Analysis:** The current price is above the 5-day moving average but below the 20-day and 60-day moving averages. This suggests a recent short-term uptrend, but the longer-term trend may still be downward. The small price increase compared to the previous close suggests a slight upward momentum, but is not significant enough to be considered a "sudden rebound" or "sharp drop."

### 3. Indicators and Signals

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 30.90 (Approaching Oversold)
*   **PPO:** -1.1767 (Below Zero - Suggests potential downtrend)
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (4 shares - Caution - MRI:0.35)
*   **Recent (20-day) Relative Divergence Change:** -1.8 (Short-term Decrease)
*   **Expected Return:** 62.6%

**Analysis:**

*   The low MRI suggests the overall market environment is relatively stable, but MRI:0.35 indicates caution.
*   The RSI is approaching oversold territory, which *could* indicate a potential buying opportunity, but it should be confirmed with other indicators.
*   The negative PPO reinforces the potential for a downtrend.
*   The hybrid signal recommends increasing the cash position and selling a small portion of holdings, indicating a cautious stance.
*   The decreasing relative divergence reinforces the recent underperformance relative to the S&P 500.
*   The high expected return suggests significant potential upside for long-term investors (2+ years), but this should be balanced with the high volatility.

### 4. Recent News & Significant Events

*   **2025-07-27:** Major business developments, regulatory changes, or market events.
*   **2025-07-26:** Analyst discussion of performance in the context of industry trends and economic factors.
*   **2025-07-25:** Stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-07-28:** Market experts highlighting risks and opportunities, advising investors to monitor news.

**Analysis:** The news snippets indicate TMDX is experiencing significant events affecting its stock price. Investors should closely monitor news releases and company announcements for details on these developments. The focus on both risks and opportunities suggests a mixed outlook.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 예상 EPS |
|------------|------|----------|
| 2025-05-08 | 0.7  | 0.29     |
| 2025-02-27 | 0.19 | 0.22     |
| 2024-10-28 | 0.12 | 0.29     |
| 2024-07-31 | 0.35 | 0.21     |
| 2024-04-30 | 0.35 | 0.03256  |

**Analysis:** The company has generally beaten EPS expectations in recent quarters, particularly the most recent quarter (2025-05-08). This suggests strong recent performance and positive earnings momentum, though there are still quarters where the actual EPS was lower than expected.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $0.14B   | 61.47%        |
| 2024-12-31 | $0.12B   | 59.21%        |
| 2024-09-30 | $0.11B   | 55.94%        |
| 2024-06-30 | $0.11B   | 60.59%        |
| 2024-03-31 | $0.10B   | 61.91%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-03-31 | $0.27B   | 9.64%   |
| 2024-12-31 | $0.23B   | 3.00%   |
| 2024-09-30 | $0.21B   | 2.01%   |
| 2024-06-30 | $0.19B   | 6.42%   |
| 2024-03-31 | $0.16B   | 7.65%   |

**Analysis:**

*   **Revenue:** Revenue has been steadily increasing over the past year, indicating growth in the company's core business.
*   **Profit Margin:** Profit margins are consistently high (above 55%), suggesting strong pricing power and efficient operations.
*   **Equity:** Equity has been increasing, reflecting the company's growing net worth.
*   **ROE:** ROE (Return on Equity) shows good profitability relative to equity, but there is variability quarter to quarter.

### 7. Overall Assessment

**Summary:** TMDX has shown significant outperformance relative to the S&P 500, but also exhibits high volatility.  Recent earnings have been strong, and revenue and profit margins are healthy and growing.

**Key Considerations:**

*   **Volatility:** The high MDD highlights the potential for significant price swings.
*   **Recent Price Action:** The stock is currently below its 20-day and 60-day moving averages, suggesting a short-term downtrend.
*   **Mixed Signals:** The RSI approaching oversold territory contrasts with the negative PPO and Hybrid Signal.
*   **Market Sensitivity:** The increasing beta suggests the stock is becoming slightly more correlated to the overall market.
*   **News & Events:** Monitor upcoming news to understand the impact of recent developments.

**Recommendation:**

Given the recent price action, mixed technical signals, and significant news events, a cautious approach is warranted. The high expected return may be attractive to long-term investors, but they should be prepared for significant volatility. Monitoring news and future earning releases will be critical. Consider the current hybrid signal of increasing cash positions.

I hope this comprehensive analysis is helpful!
